Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.
Status:
Completed
Trial end date:
2020-08-28
Target enrollment:
Participant gender:
Summary
Study to allow access to everolimus for patients who are on everolimus treatment in a
Novartis-sponsored study and are benefiting from the treatment as judged by the investigator